Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration

References

• LiY, WeiX, ZhangS, et al. A meta-analysis of palonosetron for the prevention of postoperative nausea and vomiting in adults. J Perianesth Nurs. 2015;30(5):398–405. doi:10.1016/j.jopan.2015.05.11626408514
   PubMed Web of Science ®Google Scholar
• SongY, ShimJK, SongJW, et al. Dexmedetomidine added to an opioid-based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients: a prospective, randomised controlled trial. Eur J Anaesthesiol. 2016;33(2):75–83. doi:10.1097/EJA.000000000000032726258655
   PubMed Web of Science ®Google Scholar
• RyuJH, ChangJE, KimHR, et al. Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: prospective, randomized, and double-blind study. Int J Surg. 2013;11(2):183–187. doi:10.1016/j.ijsu.2012.12.01823313969
   PubMed Web of Science ®Google Scholar
• KinnavyJJ. Utilization of preoperative risk assessment for management of postoperative nausea and vomiting (PONV). J Peroanes Nur. 2015;30(4):e9–e10. doi:10.1016/j.jopan.2015.05.030
   Google Scholar
• SanmukhaniJJ, PawarP, MittalR. Ramosetron hydrochloride for the prevention of cancer chemotherapy induced nausea and vomiting: the Indian experience. South Asian J Cancer. 2014;3(2):132–137. doi:10.4103/2278-330X.13046624818110
   PubMedGoogle Scholar
• FujiiY, SaitohY, TanakaH. A randomized, double-blind, placebo-controlled trial of ramosetron for preventing nausea and vomiting during termination of pregnancy. Int J Obstet Anesth. 2004;13(1):15–18. doi:10.1016/S0959-289X(03)00101-815321434
   PubMed Web of Science ®Google Scholar
• JakobSM, RuokonenE, GroundsRM, et al. Dexmedetomidine vs midazolapropofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151–1160. doi:10.1001/jama.2012.30422436955
   PubMed Web of Science ®Google Scholar
• ShetaSA, Al-sarheedMA, AbdelhalimAA. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Paediatr Anaesth. 2014;24(2):181–189. doi:10.1111/pan.1228724237879
   PubMed Web of Science ®Google Scholar
• YadavG, PratiharyPB, JainG, et al. A prospective, randomized, double blind and placebo-control study comparing the additive effect of oral midazolam and clonidine for postoperative nausea and vomiting prophylaxis in granisetron premedicated patients undergoing laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2013;29(1):61–65. doi:10.4103/0970-9185.10580023493482
   PubMedGoogle Scholar
• KimWJ, KangH, ShinHY, et al. Ramosetron, midazolam, and combination of ramosetron and midazolam for prevention of postoperative nausea and vomiting: a prospective, randomized, double-blind study. J Int Med Res. 2013;41(4):1203–1213. doi:10.1177/030006051348586423766412
   PubMed Web of Science ®Google Scholar
• ByonHJ, LeeSJ, KimJT, et al. Comparison of the antiemetic effect of ramosetron and combined ramosetron and midazolam in children: a double-blind, randomised clinical trial. Eur J Anaesth. 2012;29(4):192–196. doi:10.1097/EJA.0b013e32834fc1fb
   PubMed Web of Science ®Google Scholar
• ParkEY, LeeSK, KangMH, et al. Comparison of ramosetron with combined ramosetron and midazolam for preventing postoperative nausea and vomiting in patients at high risk following laparoscopic gynaecological surgery. J Int Med Res. 2013;41(3):654–663. doi:10.1177/030006051348762723660085
   PubMed Web of Science ®Google Scholar
• FangBX, ChenFC, ZhuD, et al. Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration. Oncotarget. 2017;8(63):106249–106257. doi:10.18632/oncotarget.2217429290945
   PubMedGoogle Scholar
• ChenP, ChenF, ZhouBH. Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration. Medicine. 2018;97(50):e13698. doi:10.1097/MD.000000000001369830558082
   PubMed Web of Science ®Google Scholar
• WalkerSE, GradHA, HaasDA, MayerA. Stability of parenteral midazolam in an oral formulation. Anesth Prog. 1997;44(1):17–22.9481976
   PubMedGoogle Scholar
• HeG, ZengF, LeiK, et al. Compatibility of dexamethasone sodium phosphate with 5-HT receptor antagonists in infusion solutions: a comprehensive study. Eur J Hosp Pharm. 2017;24(3):162–166. doi:10.1136/ejhpharm-2016-00098031156929
   PubMedGoogle Scholar
• ApfelCC, StoeckleinK, LipfertP. PONV: a problem of inhalational anaesthesia? Best Pract Res Clin Anaesthesiol. 2005;19(3):485–500. doi:10.1016/j.bpa.2005.03.00116013696
   PubMedGoogle Scholar
• FujiiY, SaitohY, TanakaH, ToyookaH. Prevention of PONV with granisetron, droperidol or metoclopramide in patients with postoperative emesis. Can J Anaesth. 1998;45(2):153–156. doi:10.1007/BF030132559512851
   PubMed Web of Science ®Google Scholar
• SubramaniamB, MadanR, SadhasivamS, et al. Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair. Br J Anaesth. 2001;86(1):84–93. doi:10.1093/bja/86.1.8411575416
   PubMed Web of Science ®Google Scholar
• HaganRL, JacobsLF, PimslerM, et al. Stability of midazolam hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection over 30 days. Am J Hosp Pharm. 1993;50(11):2379–2381.8266971
   PubMedGoogle Scholar
• AndersonC, MackayM. Stability of fentanyl citrate, hydromorphone hydrochloride, ketamine hydrochloride, midazolam, morphine sulfate, and pentobarbital sodium in polypropylene syringes. Pharm. 2015;3(4):379–385.
   Google Scholar
• WilsonKM, SchneiderJJ, RavenscroftPJ. Stability of midazolam and fentanyl in infusion solutions. J Pain Symptom Manage. 1998;16(1):52–58. doi:10.1016/S0885-3924(98)00024-49707657
   PubMed Web of Science ®Google Scholar
• RiggsRM, EnglishBA, WebsterAA, et al. Fosphenytoin Y-site stability studies with lorazepam and midazolam hydrochloride. Int J Pharm Compd. 1999;3(3):235.23985622
   PubMedGoogle Scholar
• WongAH, LawS, WalkerSE, et al. Concentration-dependent compatibility and stability of dexamethasone and midazolam. Can J Hosp Pharm. 2000;53(1):24–31.
   Google Scholar
• SongF. Compatibility of ramosetron hydrochloride for injection with four kinds of injections. Anhui Med Pharm J. 2008;12(1):15–16.
   Google Scholar
• BoitquinL, HecqJD, EvrardJM, et al. Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4 degrees C. J Pain Symptom Manage. 2004;28(1):4–6. doi:10.1016/j.jpainsymman.2004.04.00315223079
   PubMed Web of Science ®Google Scholar
• ErolesAA, BafalluyIM, ArnaizJA. Stability of docetaxel diluted to 0.3 or 0.9 mg/mL with 0.9% sodium chloride injection and stored in polyolefin or glass containers. Am J Health Syst Pharm. 2009;66(17):1565–1568. doi:10.2146/ajhp08048219710441
   PubMed Web of Science ®Google Scholar
• ChenF, LiP, ZhouB, et al. Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride. Eur J Hosp Pharm. 2015;22(1):7–11. doi:10.1136/ejhpharm-2014-000450
   Google Scholar